Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-400-6 | CAS number: 179986-09-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro:
In a reverse gene mutation assay in bacteria (RCC 570401, 1996), performed according to OECD guideline 471, S. typhimurium strains TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2 uvr A were exposed to the test substance (dissolved in DMSO) at concentrations of 33.3, 100, 333.3, 1000, 2500 and 5000 µg/plate in the presence and absence of mammalian metabolic activation (S9 liver microsomal fraction from phenobarbital treated rats). In the positive control groups (sodium azide, 4-nitro-o-phenylene-diamine, methyl methane sulfonate, 2-aminoanthracene) a clear increase in the number of revertants was observed (at least 13-fold). There was no evidence of induced mutant colonies over background or dose related increase in the test groups.
In a mammalian cell cytogenetics assay (chromosomal aberration; RCC 570402, 1996), performed according to OECD guideline 473,
V79 cell cultures were exposed to the test substance (dissolved in DMSO) at concentrations of 30 up to 5000 µg/ml in the presence and absence of mammalian metabolic activation (liver S9-mix from Phenobarbital/b-Naphthoflavone treated rats). Positive controls (cyclophosphamide, ethylmethanesulphonate) induced the appropriate response. In the treated groups, some aberrations were noted but no statistically significant increases in the frequency of aberrations per cell or in the proportion of aberrant metaphases at any dose level evaluated with or without S9 Mix were observed. Hence, treatment of V79 cells with the test substance revealed an ambiguous result concerning the induction of chromosomal aberrations.
In vivo:
In a NMRI mouse bone marrow micronucleus assay (RCC 582100, 1997), performed according to OECD guideline 474, 5 male and 5 female animals per dose were treated once by gavage with the test substance, which was dissolved in polyethylene glycol, at doses of 200, 670, and 2000 mg/kg bw. Bone marrow cells were harvested at 24 and 48 hours post-treatment.
During treatment of the mice, clinical signs like reduction of spontaneous activity and apathy were observed.
The positive control (cyclophosphamide) induced the appropriate increase in micronuclei. In the treated groups, there was no significant increase in the frequency of micronuclei in the bone marrow cells of mice after any treatment time.
In an unscheduled DNA synthesis assay (RCC 1160600, 2008), performed according to OECD guideline 486, 4 male Wistar rats per dose were treated once by gavage with the test substance, dissolved in polyethylene glycol, at doses of 1000 and 2000 mg/kg bw. After the treatment period of 4 and 16 hours, respectively, primary hepatocyte cultures were established and evaluated.
During treatment of the rats, clinical signs like reduction of spontaneous activity and ruffled fur observed. Both effects were reversible 24 hours after administration.
The positive controls (N,N’-dimethylhydrazinedihydrochloride, 2-acetylaminofluorene) induced the appropriate response of unscheduled DNA synthesis. In the treated groups, there was no significant increase in the frequency of unscheduled DNA synthesis in primary hepatocytes of rats after any treatment time.
Short description of key information:
Genetic toxicity in vitro:
Ames test: negative (OECD Guideline Study 471, RCC 570401, 1996)
Chromosome aberration: ambiguous (OECD Guideline Study 473, RCC 570402, 1996)
Genetic toxicity in vivo:
Micronucleus: negative (OECD Guideline Study 474, RCC 582100, 1997)
UDS: negative (OECD Guideline Study 486, RCC 1160600, 1997)
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for mutagenicity under Directive 67/548/EEC, as amended for the 28th time in Directive 2001/59/EC.
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for mutagenicity under Regulation (EC) No. 1272/2008, as amended for the second time in Directive (EC 286/2011).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.